Sara M. Tolaney
- Oncology top 0.05%
- Pulmonary and Respiratory Medicine top 0.2%
- Cancer Research top 0.2%
- Molecular Biology top 2%
- Radiology, Nuclear Medicine and Imaging top 0.5%
- Co-authors
- Romualdo Barroso‐SousaEric P. WinerSònia PernasTanya E. KeenanPaolo TarantinoIan E. KropHope S. RugoLe Min
- Topics
- Advanced Breast Cancer Therapies (237 papers)HER2/EGFR in Cancer Research (217 papers)Cancer Treatment and Pharmacology (149 papers)
- Partner nations
- United StatesSpainGermany
In The Last Decade
Sara M. Tolaney
470 papers receiving 14.6k citations
Hit Papers
Peers
Comparison fields: 5 of 141
- Oncology 11.6k
- Pulmonary and Respiratory Medicine 5.3k
- Cancer Research 3.7k
- Molecular Biology 2.8k
- Radiology, Nuclear Medicine and Imaging 2.0k
Countries citing papers authored by Sara M. Tolaney
This map shows the geographic impact of Sara M. Tolaney's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sara M. Tolaney with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sara M. Tolaney more than expected).
Fields of papers citing papers by Sara M. Tolaney
This network shows the impact of papers produced by Sara M. Tolaney. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sara M. Tolaney. The network helps show where Sara M. Tolaney may publish in the future.
Co-authorship network of co-authors of Sara M. Tolaney
This figure shows the co-authorship network connecting the top 25 collaborators of Sara M. Tolaney. A scholar is included among the top collaborators of Sara M. Tolaney based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Sara M. Tolaney. Sara M. Tolaney is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 5 | |
| 2 | 3 | |
| 3 | 3 | |
| 4 | 2 | |
| 5 | 24 | |
| 6 | 21 | |
| 7 | 21 | |
| 8 | 16 | |
| 9 | 1 | |
| 10 | 4 | |
| 11 | 90 | |
| 12 | 9 | |
| 13 | 31 | |
| 14 | 15 | |
| 15 | 144 | |
| 16 | 49 | |
| 17 | 92 | |
| 18 | 41 | |
| 19 | Impact of the Addition of Carboplatin and/or Bevacizumab to Neoadjuvant Once-per-Week Paclitaxel Followed by Dose-Dense Doxorubicin and Cyclophosphamide on Pathologic Complete Response Rates in Stage II to III Triple-Negative Breast Cancer: CALGB 40603 (Alliance)breakdown → | 650 |
| 20 | 53 |
About Sara M. Tolaney
Sara M. Tolaney is a scholar working on Oncology, Cancer Research and Pulmonary and Respiratory Medicine, having authored 502 papers that have together received 14.8k indexed citations. Recurring topics across this work include Advanced Breast Cancer Therapies (237 papers), HER2/EGFR in Cancer Research (217 papers) and Cancer Treatment and Pharmacology (149 papers). The work is most often cited by research in Oncology (11.6k citations), Cancer Research (3.7k citations) and Pulmonary and Respiratory Medicine (5.3k citations). Sara M. Tolaney has collaborated with scholars based in United States, Spain and Germany. Frequent co-authors include Romualdo Barroso‐Sousa, Eric P. Winer, Sònia Pernas, Tanya E. Keenan, Paolo Tarantino, Ian E. Krop, Hope S. Rugo, Le Min, F. Stephen Hodi and William T. Barry. Their work appears in journals such as New England Journal of Medicine, Proceedings of the National Academy of Sciences and The Lancet.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.